Achillion Pharmaceuticals (ACHN)
|
9.12
-0.08 (-0.87%)
|
|
|
|
ACHN additional information
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
ACHN Profile
•
Exchange
NASDAQ
•
Executives
Mr. Michael D. Kishbauch
Chief Exec. Officer
Pres and Director
Ms. Mary Kay Fenton
Chief Financial Officer
Principal Accounting Officer Sr. VP and Sec.
Dr. Gautam Shah Ph.D.
Chief Compliance Officer and Exec. VP
Mr. Joseph Truitt
Chief Commercial Officer and Sr. VP of Bus. Devel.
Dr. Milind S. Deshpande Ph.D.
Chief Scientific Officer and Pres of R&D
Chief Exec. Officer
Pres and Director
Ms. Mary Kay Fenton
Chief Financial Officer
Principal Accounting Officer Sr. VP and Sec.
Dr. Gautam Shah Ph.D.
Chief Compliance Officer and Exec. VP
Mr. Joseph Truitt
Chief Commercial Officer and Sr. VP of Bus. Devel.
Dr. Milind S. Deshpande Ph.D.
Chief Scientific Officer and Pres of R&D
•
Employee Count
48
Special Offers
Competitors
ACHN earnings
Date
Actual
Expected
Prev Yr Qtr
11/8/2012
-0.20
-0.17
-0.15
8/8/2012
-0.16
-0.17
-0.19
5/9/2012
-0.13
-0.15
-0.17
